Hearing Industry News
Audiology Updates
Stay current on the hearing-care landscape. This page curates the latest headlines for audiologists and private practices—covering:
- manufacturer product launches
- CMS/FDA policy shifts
- Medicare Advantage and TPA developments
- reimbursement and coding changes
- technology breakthroughs
- practical tips for clinic operations
Updated frequently, it’s a single place to scan what matters, filter by topic, and click through for deeper reading.
Industry UPDATES
- Exclusive: Peter Justesen on Amplifon’s mega-deal and the future of GN Hearing
- Cilcare Updates License Agreement with Sanofi, Brings Pharma Giant on as Equity Holder
- Free July 4 Cardiff session for lowdown on tinnitus
- The Follow-Up Gap: How Hearing Practices Lose Patients Without Realizing It
- U.S. Department of Labor Seeks Input on Future Standards for Occupational Hearing Loss Testing
- InnoCaption Wins AI Breakthrough Award for Text-to-Speech Solution
- Widex presents clarity solution for 100+ London audience of professionals
- Introducing the Career Pivot Speaker Series—Because the SLP Career Can Take Many Paths
- USC Researchers Secure $3.7M Award to Advance Cochleoscope Development, OCT-Based Inner Ear Imaging Device
- ASHA and CHSA Launch “Helping You Communicate” Campaign Targeting Caregiver Challenges
- June 2026 NeuroAudiology Newsletter
- Continued “continued growth” – Is there a more intriguing story behind 2025 hearing aid sales data?
- Knowles Introduces Balanced Armature Hybrid Driver Architecture for Over-Ear Headphones
- Tinnitus and Traumatic Brain Injury
- Integrating Tinnitus Treatment into Your Clinic
- Audiology and the RISE Rule: A Blessing in Disguise?
- Survey: Cost Concerns Driving Years-Long Delays in Hearing Care Among Tennessee Seniors
- Sanofi Takes Equity Stake in Cilcare as Hearing Therapeutics Partnership Expands
- Go Where the People with Hearing Loss Are
- Amplifon Signs €1.35B Senior Loan to Help Finance GN Hearing Acquisition
Why Verifying Hearing Aid Benefits Too Early Can Create Workflow Problems
Medicare Advantage hearing benefits have created new challenges for audiology practices. A patient who contacts your clinic for a hearing evaluation may require a different workflow than a patient referred through a third-party administrator (TPA). Learn why verifying the right benefit at the right time helps protect diagnostic billing, documentation, and patient expectations.
Manufacturer Annual Reports
Explore annual reports from top hearing aid manufacturers.
Compare results, spot market trends, and stay aligned with the strategies shaping hearing care.
Amplifon 2025
Fiscal Year: January 1 – December 31
Demant 2025
Fiscal Year: January 1 – December 31
GN Resound 2025
Fiscal Year: January 1 – December 31
Sonova 2025/2026
Fiscal Year: April 1 – March 31
WSA 2024/ 2025
Fiscal Year: October 1 – September 30
Why Verifying Hearing Aid Benefits Too Early Can Create Workflow Problems
Medicare Advantage hearing benefits have created new challenges for audiology practices. A patient who contacts your clinic for a hearing evaluation may require a different workflow than a patient referred through a third-party administrator (TPA). Learn why verifying the right benefit at the right time helps protect diagnostic billing, documentation, and patient expectations.
Easily Explain Hearing Aid TPAs to Patients
Confusion around hearing aid TPAs can lead to frustrated patients, unclear expectations, and difficult conversations. Learn how to explain the relationship between insurance companies, third-party administrators, and hearing care providers while building trust through transparency.
3 Mistakes to Avoid When Switching Audiology OMS Platforms
Switching audiology software isn’t the hard part—getting it to actually work is. Learn the 3 most common mistakes practices make when transitioning OMS platforms and how to avoid workflow breakdowns, billing issues, and missed revenue.
Content on this page is for informational purposes only. Trademarks belong to their respective owners. Links to third-party sites do not constitute endorsement.